England ranks among the worst developed nations on cancer: only 60 percent of patients survive five years after diagnosis. The country lags Norway by eight percentage points on lung cancer, Sweden by five on breast cancer. On World Cancer Day, February 4, 2026, the British government unveiled a National Cancer Plan targeting 75 percent survival by 2035. If successful, around 320,000 additional lives could be saved.
A decade behind
Breast and lung cancers describe no exceptions but rather the rule in English cancer care. A study commissioned by the British Pharmaceutical Industry Association found that British cancer patients have the worst survival rates in Europe for nine of ten major cancers. The gap is largest for common tumors: England's five-year breast cancer survival rate stands at 86 percent, Sweden's at 91 percent. For lung cancer, 19 percent of English patients survive five years; in Norway, it is 27 percent.
The cause is structural. England diagnoses cancer on average later than its European neighbors. Those diagnosed with advanced tumors have far fewer treatment options. This late diagnosis is the central lever the new cancer plan aims to shift.
What the plan includes
The plan's core is a £2.3 billion investment in diagnostic capacity: by 2029, this should enable around 9.5 million additional tests. Community diagnostic centers should operate up to twelve hours daily, seven days a week. By March 2029, the so-called 28-day standard must apply: 80 percent of all cancer patients should receive diagnosis within 28 days of referral. Currently this target is missed significantly.
For treatment, the government plans to expand robot-assisted surgery from around 70,000 to 500,000 procedures annually by 2035. National lung cancer screening should roll out nationwide by 2030. Cancer Research UK welcomed the plan and highlighted that childhood and adolescent cancer research is anchored as an explicit priority for the first time.
The staffing challenge: Ambitious goals, missing doctors
Two independent analyses temper optimism considerably. The think tank The King's Fund examined whether the NHS can actually implement the planned innovations. The result: clinical staff are lacking. Staff shortages and rising patient numbers leave personnel too little time to pilot and introduce new approaches. Concretely, the King's Fund projects by 2029 a shortage of 39 percent among radiologists and 19 percent among oncology specialists—precisely the professions diagnostic expansion needs first.
The journal The Lancet Oncology posed the question "Hollow Promises?" at the plan's publication. It noted that England has met only one measurable target from earlier NHS cancer plans. In 2025, only 70.2 percent of patients began cancer treatment within the statutory 62-day window.
What other countries have already achieved
Denmark offers the historical closest comparison. In the 1990s, Denmark's cancer care ranked among Northern Europe's worst. In 2000, the country launched its first National Cancer Plan; in 2007, the government officially classified cancer as an acute life-threatening disease and accelerated diagnostic pathways. According to WHO Europe, the five-year survival rate rose from 48 percent in 2002 to 61 percent in 2014—a 13-percentage-point gain in twelve years. Key factors were centralizing cancer surgery to fewer, better-equipped centers and consistently rolling out screening.
Australia shows what the end of such development can look like. According to the Australian Institute of Health and Welfare, five-year cancer survival in Australia from 2017 to 2021 was 70 percent, ten points above England's current baseline. For breast cancer, Australia achieves 93 percent, seven points higher than England. The driving force was a systematic national early detection program.
Both cases share the same principle: progress came not from better drugs alone but from earlier diagnosis. That is precisely the goal of England's cancer plan.
Three conditions on which the plan depends
Later this autumn, an updated NHS staffing plan should be published. It must deliver concrete training increases in radiology, oncology, and histopathology. The King's Fund has called this step a crucial decision point: without it, the cancer plan remains a wish document.
In March 2029 comes the first measurable checkpoint: the 28-day diagnosis standard should apply to 80 percent of patients. Whether this is achievable depends directly on personnel development over the next three years. By 2030, the national lung cancer screening program should operate nationwide. Lung cancer is the cancer type with the largest survival gap versus European neighbors.
If the plan delivers on its promises, England will catch up what a decade of underinvestment left behind. Denmark needed twelve years for this. England has nine.